CAH - Cardinal Health, Inc.

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

• 
  Are Investors Undervaluing Aaron's (AAN) Right Now?

  Zacks
• 
  Are Investors Undervaluing Marks and Spencer Group (MAKSY) Right Now?

  Zacks

The Zacks Analyst Blog Highlights McDonald's, W.W. Grainger and Cardinal Health

McDonald's, W.W. Grainger and Cardinal Health are included in this Analyst Blog.

3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

3 Top S&P 500 Stocks to Buy as Index Tastes 4200 Mark

Banking on recent strengths, investors should place their bets on sound stocks like McDonald's (MCD), W.W. Grainger (GWW) & Cardinal Health (CAH) that are poised to scale upward along with the broader S&P 500 Index.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Alcon (ALC) Vision Care Sales Robust, Margin Pressure Persists

For Alcon (ALC), in terms of end market, Surgical global cataract procedure growth varies significantly by region.

Globus Medical's (GMED) REFLECT Correction System Gets FDA Nod

Globus Medical's (GMED) REFLECT is intended to treat young children with progressive scoliosis, while preserving motion, stability and future modulated growth.

Here's Why Investors Should Retain LabCorp (LH) Stock for Now

Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.

• 
  New Strong Sell Stocks for June 7th

  Zacks
• 
  Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

  Zacks

Zacks.com featured highlights include Cardinal Health, Boyd Gaming, Ford Motor, NXP Semiconductors N.V and American International

Cardinal Health, Boyd Gaming, Ford Motor, NXP Semiconductors N.V and American International are part of the Zacks Screen of the Week article.

Abbott's (ABT) New Pact to Advance Clinical Trials Diversity

Abbott's (ABT) latest additions to Diversity in Clinical Trials effort expand upon the alliances, awards and the emphasis on diverse participation in its own clinical trials.

Here's Why You Should Retain Veeva Systems (VEEV) Stock Now

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.

5 Attractive Value Picks Based on Discounted PEG

Here are five stocks that meet our screening criteria - CAH, BYD, F, NXPI, AIG.

National Vision (EYE) Q1 Earnings Top Estimates, Margins Down

National Vision's (EYE) Q1 net revenues are positively impacted by the timing of unearned revenue.

Here's Why You Should Retain Patterson Companies (PDCO) Stock Now

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

• 
  New Strong Sell Stocks for June 7th

  Zacks
• 
  Here's Why Investors Should Buy Allegiant (ALGT) Stock Now

  Zacks

Why You Should Buy The Cooper Companies (COO) Stock Now

The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.

NextGen (NXGN) Behavioral Health Suite to Focus on Mental Health

NextGen's (NXGN) Behavioral Health Suite is expected to offer better access to care and improve patient outcomes.

Revvity's (PKI) Q1 Earnings Top, '23 View Below Expectations

Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.

Fresenius Medical (FMS) Q1 Earnings and Revenues Beat Estimates

Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.

Masimo (MASI) Q1 Earnings Surpass Estimates, Margins Down

Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.

DaVita (DVA) Tops Q1 Earnings Estimates, Ups FY23 EPS View

DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.

Shockwave Medical (SWAV) Q1 Earnings Top, Revenues Surge Y/Y

Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

McKesson (MCK) Q4 Earnings Beat Estimates, U.S. Sales Strong

McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.

Avanos (AVNS) Q1 Earnings and Revenues Fall Shy of Estimates

Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.

AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates

AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q1 performance.

Inogen (INGN) Q1 Earnings Beat Estimates, Revenues Lag

Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall first-quarter results reflect soft performances.